Levendowski, Daniel J.
Tsuang, Debby
Chahine, Lana M.
Walsh, Christine M.
Berka, Chris
Lee-Iannotti, Joyce K.
Salat, David
Fischer, Corrine
Mazeika, Gandis
Boeve, Bradley F.
Strambi, Luigi Ferini
Lewis, Simon J. G.
Neylan, Thomas C.
St. Louis, Erik K.
Funding for this research was provided by:
National Institutes of Health (R44AG050326)
National Institutes of Health (R33AG064271)
National Institutes of Health (RO1AG060477)
National Institutes of Health (R44AG050326)
National Institutes of Health (R44AG050326)
National Institutes of Health (R44AG050326)
National Institutes of Health (R44AG050326)
National Institutes of Health (U19 AG071754)
National Institutes of Health (RO1AG060477)
National Institutes of Health (RR024150-01)
National Health and Medical Research Council (1195830)
Article History
Received: 18 September 2024
Accepted: 5 December 2024
First Online: 28 December 2024
Change Date: 16 February 2026
Change Type: Update
Change Details: The original online version of this Article was revised: In the original version of this Article, the author Erik K. St. Louis was incorrectly indexed. The original Article has been corrected.
Declarations
:
: Mr. Levendowski and Ms. Berka would benefit financially if the Sleep Profiler intellectual property was sold to a third party. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Dr. Lee-Iannotti serves as a paid advisor to and speaker for Jazz Pharmaceuticals. Dr. Boeve receives honoraria for SAB activities for the Tau Consortium; research support from Alector, Biogen, Transposon and GE Healthcare. Dr. Lewis is a consultant for Pharmaxis Ltd.